Friday, 16 October 2026European Markets

ESSO Stock Over 10% Down At Session Start On Thursday

Loading stream...

(vianews) - shares of esso (cac 40: es.pa) slid by a staggering 10.42% to €47.30 at 10:54 est on thursday, after two consecutive sessions in a row of gains. cac 40 is falling 0.2% to €7,116.57, after three sequential sessions in a row of gains. this seems, up to now, a somewhat down trend trading session today.

esso's last close was €52.80, 27.27% under its 52-week high of €72.60.

about esso

esso s.a.f. refines, distributes, and markets refined petroleum products in france and internationally. the company's refining products include gas, gasoline, fuels and combustibles, and bitumens; petrochemical products, such as steam cracking, intermediate products, polyethylene, polypropylene, escorez, additives for petroleum products, and vistalon. it also manufactures and sells base oils, finished lubricants, white oils, and paraffins. in addition, the company operates a network of service stations under the esso and esso express brands, as well as provides greases. it offers fuels under the esso brand name and lubricants under the mobil brand. the company markets its products through a network of authorized distributors, resellers, and directly to industrial accounts. esso s.a.f. was founded in 1902 and is headquartered in nanterre, france. esso s.a.f. is a subsidiary of exxonmobil france holding s.a.s.

earnings per share

as for profitability, esso has a trailing twelve months eps of €-48.72.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 117.35%.

moving average

esso's value is under its 50-day moving average of €48.31 and under its 200-day moving average of €52.41.

revenue growth

year-on-year quarterly revenue growth grew by 81.6%, now sitting on 20.7b for the twelve trailing months.

volume

today's last reported volume for esso is 45466 which is 135.18% above its average volume of 19332.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, esso's stock is considered to be oversold (<=20).

more news about esso (es.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com